Jones Daphne E
Known title: DirectorCIK: 0001475924
Associated companies
Transaction History
| AMN | ▲ Buy | Option Exercise | 8,325 | $0 | 5/1/2026 | View on chart |
| AMN | ▼ Sell | Open Market | 791 | $87K | 6/14/2023 | View on chart |
| AMN | ▼ Sell | Open Market | 209 | $23K | 6/14/2023 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,458 | $0 | 4/21/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AMN Healthcare Maintains Outperform Rating, Target Raised to $43
Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.
AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.